DCF — PRESENCE SAINTS MARY & ELIZABETH MED
Enterprise Value: $67.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$67.8M
Enterprise Value
$10.6M
PV of Cash Flows
$57.3M
PV of Terminal Value
$92.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $375.5M | $15.7M | 4.0% | $-1.7M | $-1.6M |
| Year 2 | $386.8M | $20.1M | 5.0% | $1.1M | $0.9M |
| Year 3 | $398.4M | $24.7M | 6.0% | $4.1M | $3.1M |
| Year 4 | $410.3M | $27.4M | 7.0% | $5.8M | $3.9M |
| Year 5 | $422.6M | $29.3M | 7.0% | $6.7M | $4.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $67.8M. Terminal value accounts for 84% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$364.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.03689417315885124
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5